Syverson Strege & CO Abbott Laboratories Transaction History
Syverson Strege & CO
- $274 Million
- Q2 2024
A detailed history of Syverson Strege & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Syverson Strege & CO holds 9,783 shares of ABT stock, worth $1.11 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
9,783
Previous 2,263
332.3%
Holding current value
$1.11 Million
Previous $257,000
295.33%
% of portfolio
0.37%
Previous 0.1%
Shares
13 transactions
Others Institutions Holding ABT
# of Institutions
3,161Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA166MShares$18.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.44 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.14 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.49 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $199B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...